Underestimation of Atypical Lobular Hyperplasia and Lobular Carcinoma in Situ at Stereotaxic 11-Gauge Vacuum-Assisted Breast Biopsy

Abstract

The aims of this study are to determine the frequency of diagnosis of atypical lobular hyperplasia (ALH) and lobular carcinoma in situ (LCIS) at stereotaxic-guided 11-gauge vacuum-assisted breast biopsy (VABB) and to assess the rate of underestimation of these at subsequent surgical excision and follow-up. Moreover, we aimed to define clinical, radiological and histological features of nonpalpable lesions in core biopsies that predict the lesion upgrade. Retrospective review of 11-gauge VABB was performed to identify the underestimation rate of nonpalpable lesions diagnosed as ALH or LCIS at VABB. Thirteen cases of ALH and 36 cases of LCIS were sent to surgery, 29 cases of ALH and 14 cases of LCIS were sent to follow-up. The clinical, mammographic and histologic features were assessed. The correlation between mammographic BI-RADS score and histological B-classification for both ALH and LCIS lesions were performed by Pearson's test. Of 1,765 patients enrolled, lobular lesions (ALH and/or LCIS) occurred in 82 cases, and underestimation arose in 9 (10.9%). Two cases of underestimated ALH were upgraded to invasive lobular carcinoma and one to invasive ductal carcinoma. One case of underestimated LCIS was upgraded to ductal carcinoma in situ, two to invasive ductal carcinoma and three to invasive lobular carcinoma. The histology of the core and surgical specimens were compared. A significant difference was seen in the BI-RADS score (4–5 in 91% of underestimated lesions), and the size of the lesions (≥ 1.5 cm) for underestimated cases versus accurately diagnosed cases (p<0.001). Further significant parameters predictive for malignancy were the incomplete lesion removal by VABB and the presence of associated different breast lesions in the specimen. In conclusion, as far as ALH is concerned, we propose surgery as first choice when at least one of the following condition is respected: positive history for breast carcinoma, lesion >1.5cm, co-presence of high-risk lesions in the sample, signs of ductal involvement, high histological grading for atypia and follow-up in the other cases. Surgery is recommended in all cases of LCIS:

Keywords

atypical lobular hyperplasia lobular neoplasia biopsy VABB (vacuum-assisted breast biopsy)

References

WHO Classification of tumours. Pathology and Genetics of tumours of the breast and female genital organs. Tavassoli

Devilee

, (eds) Lyon. IARC Press 2003; 9–112;

Berg

Krebs

Campassi

Madger

Sun

. Evaluation of 14– and 11-gauge directional, vacuum-assisted biopsy probes and 14-gauge biopsy guns in a breast parenchymal model. Radiology 1997; 205:203–8

Cohen

. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: Some reasons why. Radiology 2004; 231:617–21.

Heywang-Kobrunner

Schaumloffel

Viehweg

Hofer

Buchmann

Lampe

. Minimally invasive stereotaxic vacuum core breast biopsy. Eur Radiol 1998; 8:377–85.

Sneige

Wang

Baker

. Clinical, histopathologic and biologic features of pleomorphic lobular carcinoma in situ of the breast: A report of 24 cases. Mod Pathol 2002; 10:1044–50.

Lee

Kaplan

Murray

. Underestimation of DCIS at MRI-Guided Vacuum-Assisted Breast Biopsy. AJR 2007; 189:468–74.

Noske

Pahl

Fallenberg

. Flat epithelial atypia is a common subtype of B3 breast lesions and is associated with noninvasive cancer but not with invasive cancer in final excision histology. Human Pathol 2010; 41(4):522–27.

Morris

Gardner

. Calculating confidence intervals for relative risk, odds ratios and standardised ratios and rates. In Statistics with confidence -confidence intervals and statistical guidelines. Edited by Gardner

Altman

. London: Br Med J 1995; 50–63.

Philpotts

Lee

Horvath

Lange

Carter

Tocino

. Underestimation of breast cancer with 11-gauge vacuum suction biopsy. AJR 2000; 175:1047–50

10.

Shin

Rosen

. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 2002; 126:697–701

11.

Reynolds

. Core needle biopsy of challenging benign breast conditions: A comprehensive literature review. AJR 2000; 174:1245–50

12.

Londero

Zuiani

Linda

. Lobular neoplasia: Core needle breast biopsy underestimation of malignancy in relation to radiologic and pathologic features. Breast 2008; 17:623–30

13.

Berg

Mros

Ioffe

. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 2001; 218:503–9.

14.

Irfan

Brem

. Surgical and mammographic follow-up of papillary lesions and atypical lobular hyperplasia diagnosed with stereotactic vacuum-assisted biopsy. Breast J 2002; 8:230–33.

15.

Middleton

Grant

Stephens

Stelling

Sneige

Sahin

. Lobular carcinoma in situ diagnosed by core needle biopsy: When should it be excised? Modern Pathology 2003; 16(2): 120–29.

16.

Dmystrasz

Tartter

Mizrachy

Chinitz

Smith

S Rosenbaum

Estabrook

. The significance of atypical lobular hyperplasia at percutaneous breast biopsy. Breast J 2003; 9:10–12.

17.

Bauer

Ditkoff

Schanbel

Brenin

El-Tamer

Smith

. The management of lobular neoplasia identified on percutaneous core breast biopsy. Breast J 2003; 9:4–9.

18.

Foster

Helvie

Gregory

Rebner

Nees

Paramagul

. Lobular carcinoma in situ or atypical lobular hyperplasia at core needle biopsy: Is excisional biopsy necessary? Radiology 2004; 231:813–19.

19.

Cohen

. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: Some reasons why. Radiol 2004; 231:617–21.

20.

Mahoney

Robinson-Smith

Shaughnessy

. Lobular neoplasia at 11 -Gauge Vacuum-Assisted Stereotactic Biopsy: Correlation with surgical excisional biopsy and mammographic follow-up. AJR 2006; 187:949–54

21.

Mendez

Cabanillas

Echenique

Fishier

Shields

. Mammographic features and correlation with biopsy findings using 11-gauge stereotactic vacuum-assisted breast biopsy (SVABBi). Ann Oncol 2003; 14:450–54.

22.

Nerurkar

Osin

. The diagnosis and management of pre-invasive breast disease The role of new diagnostic techniques. Breast Cancer Res 2003; 5:305–8.

23.

Ancona

Capodieci

Galiano

Mangieri

Lorusso

Gatta

. Vacuum-assisted biopsy diagnosis of atypical ductal hyperplasia and patient management. Radiol Med 2011; 116(2):276–91.

24.

Liberman

Sama

Susnik

. Lobular carcinoma in situ at percutaneous breast biopsy: Surgical findings. AJR 1999; 173:291–99.

25.

Georgian-Smith

Lawton

. Calcification of lobular carcinoma in situ of the breast. AJR 2001; 176:1255–59.

26.

Hussain

Cunnik

. Management of lobular carcinoma in situ and atypical lobula hyperplasia of the breast - a review. Eur J Surg Oncol 2011; 37(4):279–89.

27.

Dupre

Muller

Man

N Wong Chi

Le Penndu

Foil

Collet

. Follow-up of BI-RADS 3 Breast Mammograms, Results of a West France “Departement” Breast Cancer Screening Programme”. Cancer Research 2009; 69(24)4013.

28.

Baum

Hanna

Acharyya

Mahoney

Conant

Bassett

. Use of BI-RADS 3-Probably Benign Category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening. Trial Radiology 2011; 260:61–67.

29.

Rajan

Shaaban

Doll

Sharma

. New patient pathway using vacuum-assisted biopsy reduces diagnostic surgery for B3 lesions. Clin Radiol 2012; 67(3):244–9.

30.

Rakha

Lee

Jenkins

Murphy

Hamilton

Ellis

. Characterization and outcome of breast needle core biopsy diagnoses of lesions of uncertain malignant potential (B3) in abnormalities detected by mammographic screening. Int J Cancer 2011; 129 (6):1417–24.

31.

Zografos

Zagouri

Sergentanis

Nonni

Koulokeri

Dardamanis

. Vacuum-assisted breast biopsy in nonpalpable solid breast lesions without microcalcifications: The Greek experience. Diagn Interv Radiol 2008; 14:127–30.

32.

Eberl

Fox

Edge

Carter

Mahoney

. BI-RADS classification for management of abnormal mammograms. J Am Board Fam Med 2006; 19:161–64.

33.

Wiratkapun

Bunyapaiboonsri

Wibulpoprasert

Lerthsithichai

. Biopsy rate and positive predictive value for breast cancer in BI-RADS category 4 breast lesions. J Med Assoc Thai 2010; 93(7):830–7.

34.

Liberman

. Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am 2000; 38:791–807.

35.

Ottesen

Graversen

Blichert-Toft

Christensen

Andersen

. Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study. Breast Cancer Res Treat 2000; 62:197–210.